These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 22714978
1. Immunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitus. Valente T, Gella A, Solé M, Durany N, Unzeta M. J Neurosci Res; 2012 Oct; 90(10):1989-96. PubMed ID: 22714978 [Abstract] [Full Text] [Related]
2. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD. Solé M, Miñano-Molina AJ, Unzeta M. Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560 [Abstract] [Full Text] [Related]
3. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition. Solé M, Esteban-Lopez M, Taltavull B, Fábregas C, Fadó R, Casals N, Rodríguez-Álvarez J, Miñano-Molina AJ, Unzeta M. Biochim Biophys Acta Mol Basis Dis; 2019 Sep 01; 1865(9):2189-2202. PubMed ID: 31047972 [Abstract] [Full Text] [Related]
4. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A. Neurochem Int; 2006 Jun 01; 48(8):746-52. PubMed ID: 16524643 [Abstract] [Full Text] [Related]
5. Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Valente T, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N. Neurobiol Dis; 2010 Jan 01; 37(1):67-76. PubMed ID: 19778613 [Abstract] [Full Text] [Related]
6. Overexpression of semicarbazide sensitive amine oxidase in the cerebral blood vessels in patients with Alzheimer's disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Ferrer I, Lizcano JM, Hernández M, Unzeta M. Neurosci Lett; 2002 Mar 15; 321(1-2):21-4. PubMed ID: 11872247 [Abstract] [Full Text] [Related]
7. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Jiang ZJ, Richardson JS, Yu PH. Neuropathol Appl Neurobiol; 2008 Apr 15; 34(2):194-204. PubMed ID: 17971074 [Abstract] [Full Text] [Related]
8. Vascular cell lines expressing SSAO/VAP-1: a new experimental tool to study its involvement in vascular diseases. Solé M, Unzeta M. Biol Cell; 2011 Nov 15; 103(11):543-57. PubMed ID: 21819380 [Abstract] [Full Text] [Related]
9. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease. Unzeta M, Hernàndez-Guillamon M, Sun P, Solé M. Int J Mol Sci; 2021 Mar 25; 22(7):. PubMed ID: 33805974 [Abstract] [Full Text] [Related]
10. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Yu PH. Med Hypotheses; 2001 Aug 25; 57(2):175-9. PubMed ID: 11461168 [Abstract] [Full Text] [Related]
11. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. Unzeta M, Solé M, Boada M, Hernández M. J Neural Transm (Vienna); 2007 Aug 25; 114(6):857-62. PubMed ID: 17393059 [Abstract] [Full Text] [Related]
12. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. del Mar Hernandez M, Esteban M, Szabo P, Boada M, Unzeta M. Neurosci Lett; 2007 Aug 25; 384(1-2):183-7. PubMed ID: 15894424 [Abstract] [Full Text] [Related]
13. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Curr Eye Res; 2017 Dec 25; 42(12):1674-1683. PubMed ID: 28937866 [Abstract] [Full Text] [Related]
16. Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice. Wang SH, Yu TY, Tsai FC, Weston CJ, Lin MS, Hung CS, Kao HL, Li YI, Solé M, Unzeta M, Chen YL, Chuang LM, Li HY. Transl Res; 2018 Jul 25; 197():12-31. PubMed ID: 29653075 [Abstract] [Full Text] [Related]
17. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z. Am J Pathol; 1998 Oct 25; 153(4):1149-55. PubMed ID: 9777946 [Abstract] [Full Text] [Related]
18. Vascular adhesion protein-1 in human ischaemic stroke. Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S. Neuropathol Appl Neurobiol; 2008 Aug 25; 34(4):394-402. PubMed ID: 18005095 [Abstract] [Full Text] [Related]
19. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. Gironès X, Guimerà A, Cruz-Sánchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sánchez FF. Free Radic Biol Med; 2004 May 15; 36(10):1241-7. PubMed ID: 15110389 [Abstract] [Full Text] [Related]
20. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Abella A, García-Vicente S, Viguerie N, Ros-Baró A, Camps M, Palacín M, Zorzano A, Marti L. Diabetologia; 2004 Mar 15; 47(3):429-438. PubMed ID: 14968297 [Abstract] [Full Text] [Related] Page: [Next] [New Search]